Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
J. Hardy, A. Haywood, G. Gogna, Jennifer H. Martin, P. Yates, R. Greer, P. Good
Trials